1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6265106802CB27E74852580D8006F4E31
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/265106802CB27E74852580D8006F4E31!OpenDocument
18
19OpenDocument
2018.232.52.135
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Affairs Excellence

Document Excerpt: Best Practices in Managing Advisory Board Meetings: Execution and Utilization

DB Image

ID: MD-552


Features:

11 Info Graphics

9 Data Graphics

45 Metrics

5 Narratives


Pages/Slides: 4


Published: 2017


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
To download this excerpt, click "Download Free Excerpt" on the right.


To return to the study abstract to purchase the full study - click here

This excerpt includes research findings and metrics from document #5452 "Best Practices in Managing Advisory Board Meetings: Execution and Utilization."

Industries Profiled:
Pharmaceutical; Biotech; Chemical; Health Care; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Daiichi Sankyo; Gilead Sciences; Boehringer Ingelheim; Genentech; UCB Pharma; Sanofi; Teva Pharmaceutical Industries Ltd; Pfizer; Shire; ViiV Healthcare

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.